Sumitomo Mitsui Trust Holdings Inc. Has $40.79 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

Sumitomo Mitsui Trust Holdings Inc. cut its stake in Avantor, Inc. (NYSE:AVTRFree Report) by 1.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,595,075 shares of the company’s stock after selling 15,513 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned 0.24% of Avantor worth $40,786,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in Avantor during the first quarter valued at $93,000. Allspring Global Investments Holdings LLC raised its position in Avantor by 8,060.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 857,276 shares of the company’s stock valued at $21,921,000 after purchasing an additional 846,771 shares in the last quarter. Oliver Luxxe Assets LLC purchased a new stake in Avantor during the first quarter valued at about $1,538,000. Cannon Global Investment Management LLC increased its holdings in shares of Avantor by 39.6% in the first quarter. Cannon Global Investment Management LLC now owns 32,100 shares of the company’s stock worth $821,000 after buying an additional 9,100 shares during the period. Finally, Norris Perne & French LLP MI increased its holdings in shares of Avantor by 2.8% in the first quarter. Norris Perne & French LLP MI now owns 480,117 shares of the company’s stock worth $12,277,000 after buying an additional 13,047 shares during the period. 95.08% of the stock is owned by institutional investors.

Avantor Stock Performance

Avantor stock opened at $21.03 on Monday. The firm has a 50 day simple moving average of $23.33 and a 200-day simple moving average of $23.75. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $26.16. The stock has a market cap of $14.29 billion, a price-to-earnings ratio of 53.92, a price-to-earnings-growth ratio of 2.13 and a beta of 1.32.

Avantor (NYSE:AVTRGet Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $0.29 EPS. The business’s revenue for the quarter was down 5.6% compared to the same quarter last year. On average, analysts expect that Avantor, Inc. will post 1.01 EPS for the current year.

Wall Street Analysts Forecast Growth

AVTR has been the topic of several recent analyst reports. Evercore ISI cut their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, June 28th. Robert W. Baird decreased their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, April 29th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Thursday, April 18th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Avantor presently has an average rating of “Moderate Buy” and a consensus price target of $26.29.

Read Our Latest Stock Analysis on AVTR

Avantor Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Further Reading

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.